Evidence map›Paper›PMID 37166578›Full record

ArticleJournal of cancer research and clinical oncology2023

Segmentation and classification of brain tumors using fuzzy 3D highlighting and machine learning.

Khalil Mowlani, Mehdi Jafari Shahbazzadeh, Maliheh Hashemipour

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khalil MowlaniDepartment of Computer Engineering, Kerman Branch, Islamic Azad University, Kerman, Iran.
Mehdi Jafari ShahbazzadehDepartment of Electrical Engineering, Kerman Branch, Islamic Azad University, Kerman, Iran. mjafari@iauk.ac.ir.
Maliheh HashemipourDepartment of Computer Engineering, Kerman Branch, Islamic Azad University, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBrain tumors are among the most lethal forms of cancer, so early diagnosis is crucial. As a result of machine learning algorithms, radiologists can now make accurate diagnoses of tumors without resorting to invasive procedures. There are, however, a number of obstacles to overcome. To begin, classifying brain tumors presents a significant difficulty in developing the most effective deep learning framework. Furthermore, physically dividing the brain tumor is a time-consuming and challenging process that requires the expertise of medical professionals.

methodsHere, we have discussed the use of a fuzzy 3D highlighting method for the segmentation of brain tumors and the selection of suspect tumor areas based on the geometric characteristics of MRI scans. After features were extracted from the brain tumor section, the images were classified using two machine learning methods: a support vector machine technique optimized with the grasshopper optimization algorithm (GOA-SVM), and a deep neural network technique based on features selected with the genetic algorithm (GA-DNN). This classifies brain tumors into benign and malignant. Implemented on the MATLAB platform, the proposed method is evaluated for effectiveness using performance metrics like sensitivity, accuracy, specificity, and Youden index.

resultsFrom these results, it is clear that the proposed strategy is significantly superior to the alternatives. The average classification accuracy was determined to be 97.53%, 97.65%, for GA-DNN and GOA-SVM, respectively.

conclusionThese findings may be a quick and important step to detect the presence of lesions at the same time as cancerous tumors in neurology diagnosis.

Indexed as

Brain NeoplasmsNeural Networks, ComputerAlgorithmsHumansMachine LearningMagnetic Resonance ImagingBrain tumorsDeep neural networkFuzzy 3D highlightingGrasshopper optimization algorithmMRI scansSupport vector machine

Identifiers

PMID37166578
PMCPMC11797375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.